ÐÓ°ÉÔ­´´

Vertigenius, based in Dublin, is poised to become a key player in the health tech sector with its innovative wearable head sensors for vertigo treatment. The direct-to-consumer approach could appeal to individuals with persistent vertigo symptoms, offering a more convenient and targeted solution than existing treatments like medication or physical therapy. The device's potential to improve quality of life and alleviate safety risks in daily activities may attract a significant customer base, especially those who found limited relief through traditional methods. With backing from investors like Atlantic Bridge, Vertigenius has a strong foundation for growth and the potential to revolutionize vertigo treatment.